164 related articles for article (PubMed ID: 14510798)
1. Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.
Parkkari M; Paakkala AM; Salminen L; Holli K;
Acta Ophthalmol Scand; 2003 Oct; 81(5):495-9. PubMed ID: 14510798
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group.
Holli K; Valavaara R; Blanco G; Kataja V; Hietanen P; Flander M; Pukkala E; Joensuu H
J Clin Oncol; 2000 Oct; 18(20):3487-94. PubMed ID: 11032589
[TBL] [Abstract][Full Text] [Related]
4. Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.
; Pagani O; Gelber S; Price K; Zahrieh D; Gelber R; Simoncini E; Castiglione-Gertsch M; Coates AS; Goldhirsch A
Ann Oncol; 2004 Dec; 15(12):1749-59. PubMed ID: 15550579
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.
Pukkala E; Kyyrönen P; Sankila R; Holli K
Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550
[TBL] [Abstract][Full Text] [Related]
6. Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.
Lewis JD; Chagpar AB; Shaughnessy EA; Nurko J; McMasters K; Edwards MJ
Cancer; 2010 May; 116(10):2307-15. PubMed ID: 20209619
[TBL] [Abstract][Full Text] [Related]
7. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
Shinkai A; Saito W; Hashimoto Y; Ishida S
BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
O'Regan RM; Cisneros A; England GM; MacGregor JI; Muenzner HD; Assikis VJ; Bilimoria MM; Piette M; Dragan YP; Pitot HC; Chatterton R; Jordan VC
J Natl Cancer Inst; 1998 Oct; 90(20):1552-8. PubMed ID: 9790548
[TBL] [Abstract][Full Text] [Related]
9. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.
Zhou WB; Ding Q; Chen L; Liu XA; Wang S
Breast Cancer Res Treat; 2011 Aug; 128(3):625-31. PubMed ID: 21553116
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant trials of toremifene vs tamoxifen: the European experience.
Holli K
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):23-7. PubMed ID: 9556787
[TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer.
Kimura M; Tominaga T; Kimijima I; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
Breast Cancer; 2014 May; 21(3):275-83. PubMed ID: 22968626
[TBL] [Abstract][Full Text] [Related]
12. Phase II trials with toremifene in advanced breast cancer: a review.
Valavaara R
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S31-5. PubMed ID: 2149283
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
[TBL] [Abstract][Full Text] [Related]
14. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
Gundersen S
J Steroid Biochem; 1990 Jun; 36(3):233-4. PubMed ID: 2142241
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
[TBL] [Abstract][Full Text] [Related]
16. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
[TBL] [Abstract][Full Text] [Related]
17. Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.
Bertelli G; Queirolo P; Vecchio S; Angiolini C; Bergaglio M; Del Mastro L; Signorini A; Valenzano M; Venturini M
Anticancer Res; 2000; 20(5C):3659-61. PubMed ID: 11268435
[TBL] [Abstract][Full Text] [Related]
18. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer.
Gershanovich M; Hayes DF; Ellmén J; Vuorinen J
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):29-36. PubMed ID: 9165504
[TBL] [Abstract][Full Text] [Related]
19. Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene.
Tanaka T; Kato T; Ohmichi M
J Obstet Gynaecol Res; 2012 Dec; 38(12):1379-84. PubMed ID: 22612286
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication.
Modig H; Borgström S; Nilsson I; Westman G
J Steroid Biochem; 1990 Jun; 36(3):235-6. PubMed ID: 2142242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]